Tenet Healthcare Corporation
US ˙ NYSE ˙ US88033G4073

SecurityTHC / Tenet Healthcare Corporation
InsiderNadja West
This page shows the track record and history of West Nadja insider trades in Tenet Healthcare Corporation. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Nadja West in THC / Tenet Healthcare Corporation. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2020-03-16 1,000 15.4200 1,000 15.4200 15,420 364 57.5600 42,140 273.28

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

THC / Tenet Healthcare Corporation Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Nadja West in THC / Tenet Healthcare Corporation. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2026-05-27 3,000 177.3500 3,000 177.3500 532,050 8 161.3700 -47,940 -9.01
2025-12-15 2,178 197.4700 2,178 197.4700 430,090
2024-05-09 1,782 126.4100 1,782 126.4100 225,263

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

THC / Tenet Healthcare Corporation Insider Trades
Insider Transaction History
File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2026-05-28 2026-05-27 4 West Nadja THC Common Stock S - Sale D 177.3500 -3,000 -532 24,805
2026-05-26 2026-05-22 4 West Nadja THC Common Stock D - Sale to Issuer D 173.7800 -493 -86 27,805
2026-05-26 2026-05-22 4 West Nadja THC Common Stock M - Exercise D 1,333 28,298
2026-02-18 2026-02-17 4 West Nadja THC Common Stock G - Gift D -1,515 26,965
2025-12-17 2025-12-15 4 West Nadja THC Common Stock S - Sale D 197.4700 -2,178 -430 28,480
2025-05-27 2025-05-23 4 West Nadja THC Common Stock D - Sale to Issuer D 161.3300 -573 -92 30,658
2025-05-27 2025-05-23 4 West Nadja THC Common Stock M - Exercise D 1,551 31,231
2024-05-10 2024-05-09 4 West Nadja THC Common Stock S - Sale D 126.4100 -1,782 -225 29,680
2023-06-23 2023-05-26 4/A West Nadja THC Common Stock A - Award D 3,682 31,462
2023-05-30 2023-05-26 4 West Nadja THC Common Stock A - Award D 2,846 30,626
2022-05-11 2022-05-09 4 West Nadja THC Common Stock A - Award D 3,836 27,780
2021-05-11 2021-05-07 4 West Nadja THC Common Stock A - Award D 3,960 23,944
2020-06-02 2020-05-29 4 West Nadja THC Common Stock A - Award D 11,139 19,984
2020-03-17 2020-03-16 4 West Nadja THC Common Stock P - Purchase D 15.4200 1,000 15 8,845
2019-11-04 2019-10-31 4 West Nadja THC Common Stock A - Award D 7,845 7,845
P
Offener Markt oder privater Kauf von nicht-derivativen oder derivativen Wertpapieren
S
Freiverkauf oder privater Verkauf von nicht-derivativen oder derivativen Wertpapieren
A
Gewährung, Vergabe oder sonstiger Erwerb von Wertpapieren des Unternehmens (z. B. eine Option)
C
Umwandlung von Derivaten
D
Verkauf oder Rückübertragung von Wertpapieren an das Unternehmen
F
Zahlung des Ausübungspreises oder der Steuerschuld mit einem Teil der vom Unternehmen erhaltenen Wertpapiere
G
Schenkung von Wertpapieren durch oder an den Insider
K
Aktien-Swaps und ähnliche Absicherungstransaktionen
M
Ausübung oder Umwandlung eines vom Unternehmen erhaltenen derivativen Wertpapiers (z. B. einer Option)
V
Eine freiwillig auf Formular 4 gemeldete Transaktion
J
Sonstige (mit einer Fußnote zur Beschreibung der Transaktion)